1150511

Akebia Therapeutics, Inc. — FEI 3012772815

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 12, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cambridge, MA (United States)

Additional Details

Sponsor, Contract Research Organization